Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).
about
Self-report measures of medication adherence behavior: recommendations on optimal useActive assistance technology for health-related behavior change: an interdisciplinary reviewCrowdsourced health research studies: an important emerging complement to clinical trials in the public health research ecosystemQuality of life in organ transplant recipients participating in an online transplant communityAn observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection deviceThe multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.Mining online social network data for biomedical research: a comparison of clinicians' and patients' perceptions about amyotrophic lateral sclerosis treatmentsQuantifying short-term dynamics of Parkinson's disease using self-reported symptom data from an Internet social network.Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course.Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.An Innovative Approach to Informing Research: Gathering Perspectives on Diabetes Care Challenges From an Online Patient Community.The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis.Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire studyAdherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment.Online information exchanges for parents of children with a rare health condition: key findings from an online support community.An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug.Innovations in e-health.Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis.Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.'Hidden' factors influencing quality of life in patients with multiple sclerosis.Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis.Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Participatory Medicine.Patient engagement in type 2 diabetes mellitus research: what patients want.Adherence to disease-modifying therapies in patients with multiple sclerosis
P2860
Q26775742-8B5961B4-3A9D-44D4-86C1-92E680726A01Q26828951-09A97B1D-D920-4AD6-A5C7-70F97557827FQ28480448-D421FFCB-14B8-405B-AC78-A4AD4012DCABQ28658845-318E4BA2-A7C7-4D25-9BD8-03FEF2AA2135Q33774144-251C2A41-2D0E-4FB7-8675-73B42974926CQ34282494-1BE6931A-E2ED-4990-A3E7-75DD0F6E1734Q34313148-E63433BD-2F6B-4525-9988-34008B869CBAQ34560102-5F057DC0-CCEA-468C-9BAB-5FAE672A1406Q34566243-83FA8379-196F-4494-BD67-CCDEAA2F61B2Q34635468-1996E452-F2EA-47D3-9092-74804B7D502FQ35223204-19065913-0AD7-48B2-925F-C195E808BE0AQ35922482-A5616050-63A1-4696-AA5F-4FEF559429ABQ36125599-14FC0DBC-2910-466D-B6DA-902E481C9C4DQ36435733-E5B251C8-34BB-4919-8F2D-54C6AD02F619Q36761902-BE50E72B-D9F8-49FC-B386-C305514BBAF5Q36794705-5DD9F4A3-9F40-4B74-957E-FAD647FBD445Q37573148-D54BD807-B7E4-40A5-8615-AF699A3ADC1DQ37592910-5CF857DB-E467-4ECE-9F26-EE85FC11CA30Q37987991-946A01EE-6E92-4976-A254-0930884ADBE8Q38413212-20E6FAB3-65F2-4479-8E9F-7BEC19E29EACQ38587673-CD1CFF1B-501D-4BBD-B2A2-D4C4053B9650Q38631863-317AE5E2-04D8-4FBB-B6C6-FC777F118CE9Q38920487-ACE26922-8570-492E-957E-471BF9E95752Q46604857-548EA569-E64F-45CD-9DA9-80C458FB57FDQ47580871-3AEF222A-261C-435A-A310-B6F5AB4660F8Q54956049-7DA2C396-B588-4E33-9A3F-28E7268DEF3CQ58712969-9016670A-1ECC-419E-9235-2FFEF4F9BCE5
P2860
Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of an online community to ...... erence Questionnaire (MS-TAQ).
@ast
Use of an online community to ...... erence Questionnaire (MS-TAQ).
@en
Use of an online community to ...... atment Adherence Questionnaire
@nl
type
label
Use of an online community to ...... erence Questionnaire (MS-TAQ).
@ast
Use of an online community to ...... erence Questionnaire (MS-TAQ).
@en
Use of an online community to ...... atment Adherence Questionnaire
@nl
prefLabel
Use of an online community to ...... erence Questionnaire (MS-TAQ).
@ast
Use of an online community to ...... erence Questionnaire (MS-TAQ).
@en
Use of an online community to ...... atment Adherence Questionnaire
@nl
P2093
P2860
P921
P356
P1476
Use of an online community to ...... erence Questionnaire (MS-TAQ).
@en
P2093
Amit Kulkarni
Homa Dastani
Michael Massagli
P2860
P356
10.2196/JMIR.1687
P50
P577
2011-01-24T00:00:00Z